Athyrium Opportunities IV Acquisition 2 LP → RVL Pharmaceuticals plc

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on RVL Pharmaceuticals plc

Filed	Form	Filer	Stake	Shares
2023-11-01	SC	Altchem Ltd	—	—	view →
2021-11-03	SC	Altchem Ltd	—	—	view →
2021-10-14	SC	Avista Capital Partners III GP, L.P.	—	—	view →
2020-11-23	SC	Avista Capital Partners III GP, L.P.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →